YDL223C
| Product Name | YDL223C |
|---|---|
| CAS Number | 489408-02-8 |
| Synonyms | YDL-223C; YDL 223C |
| Appearance | White to off-white crystalline powder |
| Purity (HPLC) | ≥98.0% |
| Molecular Formula | C17H19F3N2O2 |
| Molecular Weight | 340.34 g/mol |
| Solubility | Soluble in DMSO, ethanol; slightly soluble in water |
| Storage | Store at -20°C, protected from light and moisture |
| Package | 10 mg, 50 mg, 100 mg, 500 mg, 1 g (bulk available) |
Need help? Contact our team

Synonyms: YDL-223C, YDL 223C
YDL223C is a synthetic small-molecule compound that has drawn interest in medicinal chemistry and early-stage drug discovery, particularly as a tool for probing protein–protein interactions and cellular signaling pathways. While its exact target profile remains under investigation, the compound’s trifluoromethyl-substituted aryl scaffold and imidazolidinedione core place it within a well-explored chemical space known for metabolic stability and membrane permeability. Researchers frequently employ YDL223C as a reference standard or screening hit in assay development, where reproducible purity and consistent solid-state form are critical.
From a structural standpoint, YDL223C features a 4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile motif—a combination that balances lipophilic and polar character. The nitrile group offers a handle for further derivatization, while the gem-dimethyl imidazolidinedione contributes to conformational rigidity. This architecture is reminiscent of non-steroidal ligands designed to engage hydrophobic pockets, making the compound a useful probe in receptor-binding studies and structure–activity relationship (SAR) campaigns.
In the broader context of chemical biology, YDL223C is typically supplied as a high-purity solid (≥98% by HPLC) to support in vitro and cell-based experiments. Its solubility in DMSO and ethanol allows straightforward preparation of stock solutions, and the compound is stable under recommended storage conditions. While not yet a commercial therapeutic, it represents a valuable research tool for teams exploring novel mechanisms in oncology, inflammation, or metabolic disease.
| Parameter | Specification |
|---|---|
| Assay (HPLC) | ≥98.0% |
| Identification | NMR, MS conform to structure |
| Loss on Drying | ≤0.5% |
| Residue on Ignition | ≤0.1% |
| Heavy Metals | ≤10 ppm |
| Microbial Limits | Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China